Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Controlled Clinical Trial
. 2021 Jan:90:107261.
doi: 10.1016/j.intimp.2020.107261. Epub 2020 Dec 5.

Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study

Alberto Hernández  1 , Montserrat Viñals  2 , Asunción Pablos  2 , Francisco Vilás  3 , Peter J Papadakos  4 , Duminda N Wijeysundera  5 , Sergio D Bergese  6 , Marc Vives  7
Affiliations
Controlled Clinical Trial

Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study

Alberto Hernández et al. Int Immunopharmacol. 2021 Jan.

Abstract

Background: There is still no specific treatment strategies for COVID-19 other than supportive management.

Design: A prospective case-control study determined by admittance to the hospital based on bed availability.

Participants: Eighteen patients with COVID-19 infection (laboratory confirmed) severe pneumonia admitted to hospital between 20th March and 19th April 2020. Patients admitted to the hospital during the study period were assigned to different beds based on bed availability. Depending on the bed the patient was admitted, the treatment was ozone autohemotherapy or standard treatment. Patients in the case group received ozonated blood twice daily starting on the day of admission for a median of four days. Each treatment involved administration of 200 mL autologous whole blood enriched with 200 mL of oxygen-ozone mixture with a 40 μg/mL ozone concentration.

Main outcomes: The primary outcome was time from hospital admission to clinical improvement.

Results: Nine patients (50%) received ozonated autohemotherapy beginning on the day of admission. Ozonated autohemotherapy was associated with shorter time to clinical improvement (median [IQR]), 7 days [6-10] vs 28 days [8-31], p = 0.04) and better outcomes at 14-days (88.8% vs 33.3%, p = 0.01). In risk-adjusted analyses, ozonated autohemotherapy was associated with a shorter mean time to clinical improvement (-11.3 days, p = 0.04, 95% CI -22.25 to -0.42).

Conclusion: Ozonated autohemotherapy was associated with a significantly shorter time to clinical improvement in this prospective case-control study. Given the small sample size and study design, these results require evaluation in larger randomized controlled trials.

Clinical trial registration number: NCT04444531.

Keywords: COVID-19; Oxygen-ozone therapy; Ozonated blood; Pneumonia; Time to clinical improvement.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Kaplan-Meier survival curves.
See this image and copyright information in PMC

References

    1. Johns Hopkins University and Medicine; COVID-19 map Johns Hopkins Coronavirus Resource Centre, https://coronavirus.jhu.edu/map.html.
    1. Chen N., Zhou M., Dong X., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi: 10.1016/S0140-6736(20)30211-7. - DOI - PMC - PubMed
    1. Zhou F., Yu T., Du R., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. - PMC - PubMed
    1. Giunta R., Coppola A., Luongo C., et al. Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease. Ann. Hematol. 2001;80(12):745–748. - PubMed
    1. Wu X.N., Zhang T., Wang J., et al. Magnetic resonance diffusion tensor imaging following major ozonated autohemotherapy for treatment of acute cerebral infarction. Neural Regen Res. 2016;11(7):1115–1121. - PMC - PubMed

Publication types

Associated data